Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hesperidin-Diosmin Effect on Metabolic Syndrome and Diabetic Neuropathy Among Patients With Type 2 Diabetes Mellitus

NCT05243238 is registered in ClinicalTrials.gov with Beni-Suef University as lead sponsor.

NCT NCT05243238
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05243238 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hesperidin-Diosmin Effect on Metabolic Syndrome and Diabetic Neuropathy Among Patients With Type 2 Diabetes Mellitus
Lead sponsor
Beni-Suef University
Phase
Not applicable
Overall status
Completed
Start date
March 1, 2020
Completion date
November 12, 2021
Enrollment
129 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic syndrome and diabetic neuropathy